Nektar Therapeutics Down Nearly 21%, on Pace for Largest Percent Decrease Since February 2023

Dow Jones
5 hours ago

Nektar Therapeutics $(NKTR)$ is currently at $47.86, down $12.68 or 20.94%

 

--Would be lowest close since Feb. 9, 2026, when it closed at $37.07

--On pace for largest percent decrease since Feb. 24, 2023, when it fell 49.66%

--Currently down three of the past five days

--Up 13.21% year-to-date

--Down 97.06% from its all-time closing high of $1626.60 on March 8, 2018

--Down 20.88% from 52 weeks ago (Oct. 2, 2025), when it closed at $60.50

--Down 52.3% from its 52-week closing high of $100.35 on April 20, 2026

--Up 36.29% from its 52-week closing low of $35.12 on Feb. 5, 2026

--Traded as low as $47.15; lowest intraday level since Feb. 10, 2026, when it hit $47.05

--Down 22.12% at today's intraday low; largest intraday percent decrease since Feb. 24, 2023, when it fell as much as 50.68%

 

All data as of 12:09:43 PM ET

 

Source: Dow Jones Market Data, FactSet

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10